Skip to content
Medical Health Aged Care

Notice Concerning Change of Representative Executive Officer

Fujirebio 2 mins read
TOKYO--BUSINESS WIRE--

H.U. Group Holdings, Inc. (the Company) today announced that it has resolved, at a meeting of the Board of Directors held on January 14, 2026, to change the Company’s Representative Executive Officer as described below.

1. Name and job titles of newly appointed Representative Executive Officer

Name

New title

Current title

Goki Ishikawa

Representative Executive Officer,
President and Group CEO

Managing Executive Officer

2. Name and job titles of retiring Representative Executive Officer

Name

New title

Current title

Shigekazu Takeuchi

Director and Executive Officer

Director, Representative Executive Officer, Chairman, President and Group CEO

3. Reason for change

In May 2025, toward realizing its Vision for 2035, the Company announced its Medium-Term Management Plan “H.U. 2030” (MMP) as well as its CEO succession plan including the timing for the selection of the next CEO. As the succession plan progressed, the Company has recognized that Mr. Goki Ishikawa is the best to lead the execution of MMP as CEO considering he has made significant contributions to the growth of the H.U. Group as an Executive Officer in charge of IVD, which led to the resolution.

4. Career summary of newly appointed Representative Executive Officer

Name : Goki Ishikawa
Date of birth : November 18, 1976
Number of shares held : 20,100 shares (As of June 2025)

Career summary :

Mar. 1999

University of Tokyo, B.A. Economics

Apr. 2000

Joined the Japan Defense Agency (currently Ministry of Defense, Japan)

Jun. 2006

Harvard Business School, M.B.A.

Sep. 2006

Joined the Boston Consulting Group

Dec. 2008

Joined Elsevier

Jan. 2012

Joined the Company

Jun. 2013

Director, Fujirebio Diagnostics Inc. (incumbent)

Apr. 2014

Director, FUJIREBIO INC.

Jun. 2014

Director, Fujirebio Europe N.V. (incumbent)

Mar. 2015

Representative Director, FUJIREBIO INC.

Apr. 2016

Representative Managing Director, FUJIREBIO INC.

Apr. 2017

Executive Vice President & Representative Director, FUJIREBIO INC.

Executive Vice President & Representative Director, Fujirebio Holdings, Inc.

Jun. 2018

President & CEO, FUJIREBIO INC.

Jun. 2020

Executive Officer of the Company

President & CEO, Fujirebio Holdings, Inc. (incumbent)

Director, FUJIREBIO INC. (incumbent)

Jun. 2023

Director, SRL, Inc. (incumbent)

Jun. 2025

Managing Executive Officer of the Company (incumbent)

5. Scheduled date of assuming office

April 1st, 2026


Contact details:

For media:
Public Relations Section, Public Relations/Sustainability Dept.
Phone: +81-3-6279-0884
Email: [email protected]

For investors and analysts:
IR/SR Dept.
Phone: +81-3-6279-0926
Email: [email protected]

Media

More from this category

  • Medical Health Aged Care
  • 23/02/2026
  • 15:14
Dementia Australia

Dementia Australia supports Moonah, Tasmania

Are you concerned about your memory or worried that someone you know may have dementia? Dementia Australia is offering support inMoonah, Tasmania on Thursday 5March,2026. It is estimated there are11,200people living with dementia inTasmania.Without a medical breakthrough this number is expected to increase to more than16,500people living with dementia by 2054.  The Dementia Australia sessions are an opportunity for people living with dementia, theircarers, family, and friends to attend free education to better understand dementia and to discuss the support and services Dementia Australia can provide. This Brain Hub is a free Brain Health Expo and is available to anyone…

  • Medical Health Aged Care
  • 23/02/2026
  • 13:28
Royal Australian College of GPs

Western Australian families shouldn’t bear the cost of keeping kids safe from meningococcal B: RACGP

The Royal Australian College of GPs (RACGP) is calling on the Western Australian Government to protect families by providing the life-saving meningococcal B vaccine for babies and teens. With 13 cases and one death in 2025, and four cases between December 2025 and January 2026 already, the RACGP is again urging the government to follow the lead of other states and act before more lives are put at risk. Meningococcal B is a rare but devastating disease, which can progress quickly and lead to death or permanent disability. Vaccination is recommended for every child aged two and under and every…

  • Contains:
  • Medical Health Aged Care
  • 23/02/2026
  • 10:03
The Australian Nursing and Midwifery Federation (ANMF)

ANMF appoints Catelyn Richards new Federal Assistant Secretary

The Australian Nursing and Midwifery Federation’s Federal Executive (ANMF), has appointed Catelyn Richards as its new Federal Assistant Secretary, marking a significant step in strengthening national leadership of the country’s largest union. Ms Richards is a Registered Nurse who commenced her career in paediatrics at the Royal Children’s Hospital in Melbourne. She has extensive experience in workforce advocacy and climate and health policy, having served as the ANMF’s first-ever Climate Change Officer since February, 2025. In that role, she worked to ensure that nursing and midwifery professionals had a voice in the development and implementation of national climate change policies.…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.